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Using PCR in conjunction with pre-enrichment culture, 
we detected Bartonella henselae and B. vinsonii subspe-
cies berkhofﬁ  i in the blood of 14 immunocompetent persons 
who had frequent animal contact and arthropod exposure.
A
ttempts to isolate Bartonella sp. from immunocompe-
tent persons with serologic, pathologic, or molecular 
evidence of infection are often unsuccessful; several inves-
tigators have indicated that Bartonella isolation methods 
need to be improved (1–4). By combining PCR and pre-
enrichment culture, we detected B. henselae and B. vinso-
nii subspecies berkhofﬁ  i infection in the blood of immu-
nocompetent persons who had arthropod and occupational 
animal exposure.
The Study
From November 2004 through June 2005, blood and 
serum samples from 42 persons were tested, and 14 com-
pleted  a questionnaire, approved by the North Carolina 
State University Institutional Review Board. Age, sex, 
animal contact, history of bites, environment, outdoor ac-
tivity, arthropod contact, travel, and medical history were 
surveyed. Bacterial isolation, PCR ampliﬁ  cation, and clon-
ing were performed by using previously described methods 
(5–7). Each blood sample was tested by PCR after direct 
DNA extraction, pre-enrichment culture for at least 7 days, 
and subculture onto a blood agar plate (Figure). An unin-
oculated, pre-enrichment culture was processed simultane-
ously as a control. Methods used for DNA extraction and 
conventional and real-time PCR targeting of the Bartonella 
16S-23S intergenic spacer (ITS) region and heme-binding 
protein (Pap31) gene have been described (7,8). Conven-
tional PCR amplicons were cloned with the pGEM-T Easy 
Vector System (Promega, Madison, WI, USA); sequenc-
ing was performed by Davis Sequencing, Inc. (Davis, CA, 
USA). Sequences were aligned and compared with Gen-
Bank sequences with AlignX software (Vector NTI Suite 
6.0 (InforMax, Inc., Bethesda, MD, USA) (7,8). B. vinsonii 
subsp. berkhofﬁ  i, B. henselae, and B. quintana antibodies 
were determined by using a modiﬁ  cation of a previously 
described immunoﬂ  uorescence antibody assay (IFA) pro-
cedure (9).
Study participants included 12 women and 2 men, 
ranging in age from 30 to 53 years; all of them reported oc-
cupational animal contact for >10 years (Table). Most had 
daily contact with cats (13 persons) and dogs (12 persons). 
All participants reported animal bites or scratches (primar-
ily from cats) and arthropod exposure, including ﬂ  eas, 
ticks, biting ﬂ  ies, mosquitoes, lice, mites, or chiggers. All 
participants reported intermittent or chronic clinical symp-
toms, including fatigue, arthralgia, myalgia, headache, 
memory loss, ataxia, and paresthesia (Table). Illness was 
most frequently mild to moderate in severity, with a wax-
ing and waning course, and all but 2 persons could perform 
occupational activities. Of the 14 participants, 9 had been 
evaluated by a cardiologist, 8 each by an infectious disease 
physician or a neurologist, and 5 each by an internist or 
a rheumatologist. Eleven participants had received antimi-
crobial drugs. 
When reciprocal titers of >64 were used, 8 persons 
were seroreactive to Bartonella antigens (online Appendix 
Table, available from www.cdc.gov/eid/content/13/6/938-
appT.htm). B. henselae or B. vinsonii subsp. berkhofﬁ  i was 
detected or isolated from all 14 participants. At the time 
of initial testing, Bartonella DNA was ampliﬁ  ed directly 
from 3 blood samples, from 7 pre-enrichment liquid cul-
tures, and from 4 subculture isolates (Online Table). For 5 
persons, results of PCR and culture of initial samples were 
negative. Overall, Bartonella DNA was ampliﬁ  ed  from 
11 (28%) of 40 extracted blood samples, 13 (33%) of 40 
pre-enrichment cultures, and 5 isolates. For 7 persons, B. 
henselae DNA was ampliﬁ  ed at multiple time points. Bar-
tonella DNA was never ampliﬁ  ed from any PCR control or 
uninoculated culture control.
By using the ITS target region, 2 distinct B. henselae 
ITS and Pap31 strains were sequenced, B. henselae Hous-
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ton I (HI) (GenBank NC-005956) and B. henselae San An-
tonio 2 (SA2) (GenBank AF369529). Within the noncoding 
ITS region, B. henselae SA2 strains have a 30-bp insertion 
(ATT GCT TCT AAA AAG ATT GCT TCT AAA AAG) 
located 518 bases downstream from the 16S gene. Only B. 
vinsonii subsp. berkhofﬁ  i types I and II were detected (8).
Conclusions
Persistent human infection with B. bacilliformis and B. 
quintana has been previously documented, whereas infec-
tion with B. henselae (cat-scratch disease [CSD]) is gener-
ally considered self-limiting (1,2,10). Recently, B. henselae 
DNA was ampliﬁ  ed from the blood of a child 4 months after 
CSD diagnosis (11). Our study indicates that B. henselae 
and B. vinsonii subsp. berkhofﬁ  i can induce occult infec-
tion in immunocompetent persons and that detection can be 
enhanced by combining PCR with pre-enrichment culture. 
Considering only the results from initial blood samples, 
PCR detected Bartonella DNA in 3 samples, all of which 
were subsequently PCR positive by subculture or enrich-
Table. Selected demographic, epidemiologic, and medical information reported by 14 immunocompetent persons infected with 
Bartonella henselae or B. vinsonii subsp. berkhoffii*
Study participant no. Characteristic/
symptom 123456789 1 0 1 1 1 2 1 3 1 4
Total, 
N = 14 
S e x FFFFFFMFFFFFMF
A g e ,  y 5 13 04 84 45 35 03 23 34 85 35 23 95 2 4 4
State of 
residence
NC NC NC CO VA CA NC VA CA CA CA CA VA MN
Occupational
animal exposure
V VtA AHR V V CR VtA VtA VtA VtA VtA V WB WB
Daily contact 
with dogs/cats
Y/Y Y/N N/Y Y/Y Y/Y Y/Y Y/Y Y/Y Y/Y Y/Y Y/Y Y/Y N/Y Y/Y
Contact with 
fleas/ticks†
2/1 3/3 4/4 4/4 3/3 2/3 3/3 2/2 4/4 2/4 3/1 3/2 NA/3 4/3
Self-health
assessment‡
CI CI II II II CI CI CI CI II II CI II CI
F a t i g u e ++ –++++++++++ + 1 3
J o i n t  p a i n ++ –+ +++–++++U 1 0
Difficulty 
sleeping
(insomnia)
++ ––+–++++++– – 9
Muscle pain + + – – U + + – + U + + + 8
Difficulty 
remembering
++ ––+–+++++––U 8
Loss of 
sensation or 
numbness
+++– +–+– ++–U 7
Balance
problems
+ ––++++– ++– – 7
Headache + + – – + + + – + + U 7
T r e m o r s + –– –++–+++– – 6
Irritability + – – – + + + + – – + 6
Bowel or 
bladder
dysfunction
+ –+ +–+– +–+ – 6
Eye pain + – + + + + – – – – – 5
Blurred vision + – – – + + – + + – – – 5
Sleepiness + – – – + – – + + – – + 5
Syncope or 
fainting
episodes
+++–++––– ––– – 5
Shortness of 
breath
+– + – + + –+ – – U 5
Muscle
weakness
+ –– + –+++–U 5
*F, female; M, male; NC, North Carolina, CO, Colorado, VA, Virginia; CA, California, MN, Minnesota; V, veterinarian; VtA, veterinary assistant; AHR, 
animal health researcher; CR, cattle rancher; WB, wildlife biologist; Y, yes; N, no, with respect to the study participant’s daily contact with dogs/cats; CI, 
chronically ill; II, infrequently ill; +, yes; –, no; blank,  no answer reported; U, unknown.
†Reported as frequencies and defined as follows: 1, daily; 2, infrequently (weekly); 3, occasionally (monthly); 4, almost never (yearly). 
‡Self-health assessment: As part of the questionnaire, study participants were asked to rate their own health status: healthy, infrequently ill, or chronically 
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ment culture. In samples from 5 persons, pre-enrichment 
was necessary, and in 5 other persons, sequential sampling 
was necessary to detect Bartonella infection. Intermittent 
bacteremia, as occurs in B. henselae–infected cats (12), anti-
microbial drug administration, low bacterial copy numbers, 
and low inoculum volume (1 mL) may have contributed to 
intermittent detection or inability to isolate Bartonella spp. 
from some participant samples. Although our approach is 
an improvement over historical isolation approaches, our 
results emphasize ongoing limitations associated with the 
detection of Bartonella infection. Obtaining stable Barton-
ella subcultures (n = 5 in this study) has proven problem-
atic for other specialized laboratories that routinely culture 
for Bartonella spp. (3,4). To our knowledge, the B. vinsonii 
subsp. berkhofﬁ  i type II isolate described in our study is 
the only type II human isolate reported to date (8). Various 
combinations of B. henselae and B. vinsonii subsp. berk-
hofﬁ  i strain types were detected in the same blood sample 
or sequential blood samples. The coexistence of B. hense-
lae genetic variants has been described among primary pa-
tient isolates, which suggests that multiple genotypes may 
emerge within the same person (13).
Overall, 57% of persons tested were seroreactive to 1 
or all 3 Bartonella test antigens. Previous reports from the 
United States identiﬁ  ed a B. henselae seroprevalence of 3% 
in healthy blood donors and a cumulative seroprevalence of 
7.1% to both B. henselae and B. quintana antigens in vet-
erinary professionals (1). In this and other studies, serolog-
ic test results did not correlate with PCR ampliﬁ  cation or 
isolation results. Antigenic variability among B. henselae 
test strains can cause false-negative IFA results in persons 
with suspected CSD. Also B. henselae, B. quintana, or B. 
elizabethae antibodies were not detected in some persons 
with DNA evidence of active infection (1,3,4).
Animal contact, often to a wide spectrum of domes-
tic and wild animal species, is an obvious consequence of 
the daily activities of the study population, which is biased 
by veterinary occupational exposure and by self-selection 
(volunteer bias). Cats are considered the primary reser-
voir host for B. henselae, whereas coyotes and foxes are 
considered reservoir hosts for B. vinsonii subsp. berkhofﬁ  i 
(1,2,8). Detection of B. vinsonii subsp. berkhofﬁ  i in 4 of 5 
Californian participants could be related to the high preva-
lence of bacteremic coyotes in this region as well as to the 
potential transmission by a tick vector (1,2). All 14 par-
ticipants reported frequent arthropod exposure. Although 
Bartonella spp.transmission by ticks has not been proven, 
several recent studies have identiﬁ  ed Bartonella DNA in 
questing ticks, ticks attached to animals, and ticks attached 
to humans (1,2,14).
Despite reporting chronic or episodic illness, most 
participants continued to effectively maintain daily profes-
sional and personal activities. The symptoms described in 
the study patients are very similar to those described in a 
community and hospital-based surveillance study of CSD 
patients, in whom CSD-associated arthropathy was an un-
common chronic syndrome affecting mostly young and 
middle-age women (15). Our study was initiated to investi-
gate the feasibility of combining PCR with pre-enrichment 
culture. Prospective studies, with appropriate controls, 
are needed to characterize the prevalence and clinical rel-
evance of persistent Bartonella infection in immunocom-
petent persons.
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